CMIC Group

Activities: Manufacturing

Trending Articles

  1. From RAGs to riches: AI in pharma Mirit Eldor, Managing Director, Life Sciences Solutions at Elsevier, reflects on the growth and future of AI in the pharmaceutical industry
  2. Lonza Capsules & Health Ingredients expands capsule manufacturing capacity in India and China New capsule manufacturing lines added at Lonza Capsules & Health Ingredients (CHI) facilities in Rewari (IN) and Suzhou (CN), highlighting the long-term strategic commitment to...
  3. Santhera and Clinigen partner to distribute DMD treatment AGAMREE to eligible patients globally Clinigen Group will be respsonsible for the distribution of Duchenne muscular dystrophy (DMD) treatment AGAMREE (vamorolone) in regions not currently covered by Santhera or its...
  4. Neuraxpharm bolsters its CNS-targeting therapeutic range with narcolepsy drugs Nuvigil and Provigil By acquiring Teva Pharmaceutical's Nuvigil and Provigil, Neuraxpharm hopes to enhance its narcolepsy offering, while also expanding its global presence
  5. NMD Pharma's drug candidate for Charcot-Marie-Tooth disease granted ODD by the FDA The small molecule CIC-1 inhibitor will be used to treat CMT, which currently has no approved treatments

Upcoming event

EMPQ Essentials and Real-World Strategies for Successful Cleanroom Qualifications

16 January 2025 | Virtual See all

Related Content

Manufacturing

CMIC Group establishes biopharma CDMO in Japan

Single-use facility in Shizuoka, Japan has been established to provide process development and GMP manufacturing of antibody drugs using mammalian cell line
Subscribe now